These included, for instance, lower use of core biopsy and higher reporting of tumor grade, ER/PgR expression, and HER2 amplification, pathological stage, and distance to the nearest radial margin in noninvasive cancers in general hospitals compared to oncology centers. The gene discussed is ERBB2; the disease is cancer.